ArticleAmerican journal of physiology. Heart and circulatory physiology2022

Smad3 promotes adverse cardiovascular remodeling and dysfunction in doxorubicin-treated hearts.

Melissa S Cobb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.